ODI MEDICAL AS
ODI Medical – Microcirculation & Non-invasive Technology
ODI technology could be as big
as ultra-sound
We are in a desperate need for
something like this concept
If ODI technology delivers its potential – it can save patient morbidity but also expensive care in ICU
Microcirculation delivers oxygen to all
Links
Organization
- CEO
- JU
Jørn Ulheim1969
- Chairman of the board
- AW
Anders Wold1958
- Years since formation
- 11 years
- since Sep 8, 2014
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 5
Ownership
- Number of shares and share classes
- 168,605
- 1 share class
- Total number of shareholders
- 52
- 35 companies, 17 persons
Financials
- Total operating income 2024
- 77,487
- NOK
- Annual total result 2024
- -11,702,378
- NOK
- Total equity 2024
- 31,179,274
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
JU 1969 | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
KK 1949 | Board Member | 8.6 % directly 7.52 % indirectly 1.08 % |
KD 1957 | Board Member | 3.67 % indirectly |
NB 1965 | Board Member | - |
LR | Board Member | - |
TE 1951 | Board Member | 3.03 % indirectly |
AW 1958 | Chairman | - |
Others
Name | Role | Shares |
---|---|---|
Auditor | - | |
Accountant | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
FT | - | 13.57 % indirectly |
AK 1980 | - | 13.57 % indirectly |
KK 1949 | Board Member | 8.6 % directly 7.52 % indirectly 1.08 % |
AJ | - | 5.93 % indirectly |
KD 1957 | Board Member | 3.67 % indirectly |
TE 1951 | Board Member | 3.03 % indirectly |
AC | - | 2.89 % indirectly |
HM 1958 | - | 2.89 % indirectly |
IK | - | 1.9 % directly |
MS | - | 1.9 % directly |
Last update: Jan 31, 2025
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
NO0010858343 | 50,877 | 30.18 % | |
NO0010858343 | 20,510 | 12.16 % | |
KK 1949 | NO0010858343 | 12,681 | 7.52 % |
NO0010858343 | 10,000 | 5.93 % | |
NO0010858343 | 9,375 | 5.56 % | |
NO0010858343 | 9,375 | 5.56 % | |
NO0010858343 | 7,592 | 4.5 % | |
NO0010858343 | 6,185 | 3.67 % | |
NO0010858343 | 4,662 | 2.77 % | |
NO0010858343 | 3,882 | 2.3 % | |
AK | NO0010858343 | 3,200 | 1.9 % |
KK | NO0010858343 | 3,200 | 1.9 % |
IK | NO0010858343 | 3,200 | 1.9 % |
MS | NO0010858343 | 3,200 | 1.9 % |
NO0010858343 | 2,571 | 1.52 % | |
NO0010858343 | 2,508 | 1.49 % | |
NO0010858343 | 1,819 | 1.08 % | |
NO0010858343 | 1,550 | 0.92 % | |
PØ 1948 | NO0010858343 | 1,355 | 0.8 % |
NO0010858343 | 777 | 0.46 % | |
NO0010858343 | 768 | 0.46 % | |
NO0010858343 | 714 | 0.42 % | |
NO0010858343 | 705 | 0.42 % | |
EG | NO0010858343 | 675 | 0.4 % |
KP | NO0010858343 | 675 | 0.4 % |
NO0010858343 | 662 | 0.39 % | |
NO0010858343 | 528 | 0.31 % | |
AW 1958 | NO0010858343 | 500 | 0.3 % |
NO0010858343 | 500 | 0.3 % | |
NO0010858343 | 423 | 0.25 % | |
AL | NO0010858343 | 400 | 0.24 % |
NO0010858343 | 360 | 0.21 % | |
SM 1975 | NO0010858343 | 338 | 0.2 % |
NO0010858343 | 300 | 0.18 % | |
NO0010858343 | 270 | 0.16 % | |
OC | NO0010858343 | 263 | 0.16 % |
NO0010858343 | 219 | 0.13 % | |
NO0010858343 | 200 | 0.12 % | |
NO0010858343 | 176 | 0.1 % | |
NO0010858343 | 176 | 0.1 % | |
NO0010858343 | 176 | 0.1 % | |
NO0010858343 | 175 | 0.1 % | |
NO0010858343 | 159 | 0.09 % | |
NO0010858343 | 153 | 0.09 % | |
NO0010858343 | 150 | 0.09 % | |
NO0010858343 | 125 | 0.07 % | |
JA | NO0010858343 | 100 | 0.06 % |
NO0010858343 | 90 | 0.05 % | |
NO0010858343 | 70 | 0.04 % | |
AL 1986 | NO0010858343 | 26 | 0.02 % |
MK 1943 | NO0010858343 | 5 | < 0.01 % |
GL | NO0010858343 | 5 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 77,487 | 33,614 | 480,071 | 3,141,892 |
Annual Total Result | -11,702,378 | -12,096,490 | -13,955,494 | -11,609,728 |
Total assets | 34,442,850 | 39,930,575 | 16,322,813 | 22,488,499 |
Total liabilities | 3,263,576 | 5,120,123 | 2,149,472 | 2,164,864 |
Total equity | 31,179,274 | 34,810,452 | 14,173,342 | 20,323,636 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 77,487 | 33,614 | 480,071 | 3,141,892 |
Total operating costs | 11,726,378 | 11,289,297 | 14,373,117 | 14,722,419 |
Operating result | -11,648,891 | -11,255,683 | -13,893,046 | -11,580,528 |
Financial income/costs | -53,488 | -840,806 | -62,448 | -29,200 |
Profit before tax | -11,702,378 | -12,096,490 | -13,955,494 | -11,609,728 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -11,702,378 | -12,096,490 | -13,955,494 | -11,609,728 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 24,496,138 | 19,698,833 | 8,062,917 | 4,724,416 |
Total current assets | 9,946,712 | 20,231,743 | 8,259,896 | 17,764,084 |
Total assets | 34,442,850 | 39,930,575 | 16,322,813 | 22,488,499 |
Short term debt | 2,139,698 | 3,250,226 | 2,149,472 | 2,164,864 |
Long term debt | 1,123,878 | 1,869,897 | 0 | 0 |
Total liabilities | 3,263,576 | 5,120,123 | 2,149,472 | 2,164,864 |
Contributed capital | 31,179,274 | 34,810,452 | 14,173,342 | 20,323,636 |
Retained earnings | 0 | 0 | 0 | 0 |
Total equity | 31,179,274 | 34,810,452 | 14,173,342 | 20,323,636 |
Total equity and liabilities | 34,442,850 | 39,930,575 | 16,322,813 | 22,488,499 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises